Cytokine Regulation of Human Monocyte Differentiation in Vitro

The Tumor-Cytotoxic Phenotype Induced by Macrophage Colony-stimulating Factor Is Developmentally Regulated by y-Interferon

David H Munn, Elissa Armstrong

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

In this study we continue our examination of the unique form of antibody-dependent antitumor cytotoxicity (ADCC) which develops when human monocytes are exposed to macrophage colony-stimulating factor (MCSF) in vitro. This form of ADCC is not present in fresh monocytes and emerges only as monocytes differentiate into monocyte-derived macrophages (MDM). We now report that the presence of y-interferon (IFN-y) during this period of differentiation markedly affects the development of MCSF-induced cytotoxicity. The addition of IFN-y on day 0 resulted in a pronounced dose-dependent inhibition of ADCC measured on day 7 (mean inhibition, 76 12%; range, 66-94%). MDM exposed to MCSF plus IFN-y required 3-10-fold higher effector to target cell ratios to achieve a level of cytotoxicity comparable to that of MDM cultured with MCSF alone. This inhibitory effect was attributable to an IFN-γ-induced shift in the basic mechanism of target cell killing, away from the phagocytic form normally seen with MCSF and toward a significantly less effective extracellular form. In order to influence ADCC, IFN-y had to be present prior to the onset of differentiation; if it was added later it had progressively less effect, and if it was added after differentiation was complete it was inactive. The modulatory effects of IFN-y also extended to a number of other developmentally regulated attributes. MDM cultured with MCSF normally acquired a characteristic morphology and mmunophenotype, reentered the cell cycle, and changed functionally from accessory cells for mitogen-induced lymphocyte activation to suppressor cells. The presence of IFN-y prevented the emergence of each of these attributes. Despite these negative effects, MDM exposed to IFN-y remained viable, continued to bind and internalize MCSF, and displayed superior accessory cell function and oxidative burst activity. Taken together, our findings suggest that human monocytes are capable of following at least two distinct differentiation pathways in response to the local cytokine environment, with significant impact on the resultant macrophage phenotype in general and antitumor cytotoxicity in particular.

Original languageEnglish (US)
Pages (from-to)2603-2613
Number of pages11
JournalCancer Research
Volume53
Issue number11
StatePublished - Jan 1 1993

Fingerprint

Macrophage Colony-Stimulating Factor
Interferons
Monocytes
Cytokines
Phenotype
Macrophages
Neoplasms
Antibodies
Respiratory Burst
Lymphocyte Activation
In Vitro Techniques
Mitogens
Cell Cycle

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{121871b749334c3883bc9fae8008f763,
title = "Cytokine Regulation of Human Monocyte Differentiation in Vitro: The Tumor-Cytotoxic Phenotype Induced by Macrophage Colony-stimulating Factor Is Developmentally Regulated by y-Interferon",
abstract = "In this study we continue our examination of the unique form of antibody-dependent antitumor cytotoxicity (ADCC) which develops when human monocytes are exposed to macrophage colony-stimulating factor (MCSF) in vitro. This form of ADCC is not present in fresh monocytes and emerges only as monocytes differentiate into monocyte-derived macrophages (MDM). We now report that the presence of y-interferon (IFN-y) during this period of differentiation markedly affects the development of MCSF-induced cytotoxicity. The addition of IFN-y on day 0 resulted in a pronounced dose-dependent inhibition of ADCC measured on day 7 (mean inhibition, 76 12{\%}; range, 66-94{\%}). MDM exposed to MCSF plus IFN-y required 3-10-fold higher effector to target cell ratios to achieve a level of cytotoxicity comparable to that of MDM cultured with MCSF alone. This inhibitory effect was attributable to an IFN-γ-induced shift in the basic mechanism of target cell killing, away from the phagocytic form normally seen with MCSF and toward a significantly less effective extracellular form. In order to influence ADCC, IFN-y had to be present prior to the onset of differentiation; if it was added later it had progressively less effect, and if it was added after differentiation was complete it was inactive. The modulatory effects of IFN-y also extended to a number of other developmentally regulated attributes. MDM cultured with MCSF normally acquired a characteristic morphology and mmunophenotype, reentered the cell cycle, and changed functionally from accessory cells for mitogen-induced lymphocyte activation to suppressor cells. The presence of IFN-y prevented the emergence of each of these attributes. Despite these negative effects, MDM exposed to IFN-y remained viable, continued to bind and internalize MCSF, and displayed superior accessory cell function and oxidative burst activity. Taken together, our findings suggest that human monocytes are capable of following at least two distinct differentiation pathways in response to the local cytokine environment, with significant impact on the resultant macrophage phenotype in general and antitumor cytotoxicity in particular.",
author = "Munn, {David H} and Elissa Armstrong",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "53",
pages = "2603--2613",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Cytokine Regulation of Human Monocyte Differentiation in Vitro

T2 - The Tumor-Cytotoxic Phenotype Induced by Macrophage Colony-stimulating Factor Is Developmentally Regulated by y-Interferon

AU - Munn, David H

AU - Armstrong, Elissa

PY - 1993/1/1

Y1 - 1993/1/1

N2 - In this study we continue our examination of the unique form of antibody-dependent antitumor cytotoxicity (ADCC) which develops when human monocytes are exposed to macrophage colony-stimulating factor (MCSF) in vitro. This form of ADCC is not present in fresh monocytes and emerges only as monocytes differentiate into monocyte-derived macrophages (MDM). We now report that the presence of y-interferon (IFN-y) during this period of differentiation markedly affects the development of MCSF-induced cytotoxicity. The addition of IFN-y on day 0 resulted in a pronounced dose-dependent inhibition of ADCC measured on day 7 (mean inhibition, 76 12%; range, 66-94%). MDM exposed to MCSF plus IFN-y required 3-10-fold higher effector to target cell ratios to achieve a level of cytotoxicity comparable to that of MDM cultured with MCSF alone. This inhibitory effect was attributable to an IFN-γ-induced shift in the basic mechanism of target cell killing, away from the phagocytic form normally seen with MCSF and toward a significantly less effective extracellular form. In order to influence ADCC, IFN-y had to be present prior to the onset of differentiation; if it was added later it had progressively less effect, and if it was added after differentiation was complete it was inactive. The modulatory effects of IFN-y also extended to a number of other developmentally regulated attributes. MDM cultured with MCSF normally acquired a characteristic morphology and mmunophenotype, reentered the cell cycle, and changed functionally from accessory cells for mitogen-induced lymphocyte activation to suppressor cells. The presence of IFN-y prevented the emergence of each of these attributes. Despite these negative effects, MDM exposed to IFN-y remained viable, continued to bind and internalize MCSF, and displayed superior accessory cell function and oxidative burst activity. Taken together, our findings suggest that human monocytes are capable of following at least two distinct differentiation pathways in response to the local cytokine environment, with significant impact on the resultant macrophage phenotype in general and antitumor cytotoxicity in particular.

AB - In this study we continue our examination of the unique form of antibody-dependent antitumor cytotoxicity (ADCC) which develops when human monocytes are exposed to macrophage colony-stimulating factor (MCSF) in vitro. This form of ADCC is not present in fresh monocytes and emerges only as monocytes differentiate into monocyte-derived macrophages (MDM). We now report that the presence of y-interferon (IFN-y) during this period of differentiation markedly affects the development of MCSF-induced cytotoxicity. The addition of IFN-y on day 0 resulted in a pronounced dose-dependent inhibition of ADCC measured on day 7 (mean inhibition, 76 12%; range, 66-94%). MDM exposed to MCSF plus IFN-y required 3-10-fold higher effector to target cell ratios to achieve a level of cytotoxicity comparable to that of MDM cultured with MCSF alone. This inhibitory effect was attributable to an IFN-γ-induced shift in the basic mechanism of target cell killing, away from the phagocytic form normally seen with MCSF and toward a significantly less effective extracellular form. In order to influence ADCC, IFN-y had to be present prior to the onset of differentiation; if it was added later it had progressively less effect, and if it was added after differentiation was complete it was inactive. The modulatory effects of IFN-y also extended to a number of other developmentally regulated attributes. MDM cultured with MCSF normally acquired a characteristic morphology and mmunophenotype, reentered the cell cycle, and changed functionally from accessory cells for mitogen-induced lymphocyte activation to suppressor cells. The presence of IFN-y prevented the emergence of each of these attributes. Despite these negative effects, MDM exposed to IFN-y remained viable, continued to bind and internalize MCSF, and displayed superior accessory cell function and oxidative burst activity. Taken together, our findings suggest that human monocytes are capable of following at least two distinct differentiation pathways in response to the local cytokine environment, with significant impact on the resultant macrophage phenotype in general and antitumor cytotoxicity in particular.

UR - http://www.scopus.com/inward/record.url?scp=0027316304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027316304&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 2603

EP - 2613

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 11

ER -